Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - mycoplasma hyopneumoniae - inactivated antigen; cpcv 1-2 inactivated suspension; thiomersal - misc. vaccines or anti sera - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 1.0 rp; cpcv 1-2 inactivated suspension vaccine-virus active 1.0 rp; thiomersal mercury other 0.1 mg/ml - immunotherapy

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0) - for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, nausea, and cognitive problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, nausea, and cognitive problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies).to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies.to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies).mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

European Union - English - EMA (European Medicines Agency)

virbac s.a. - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - mycoplasma gallisepticum strain alder s6 - diagnostic agents - poultry | turkeys | breeder | breeders | broiler | broiler breeder | chickens | chicks | chooks | day old chicks | hatchlings | - not applicable (vet)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - mycoplasma synoviae strain atcc wvu-1853 - diagnostic agents - poultry | turkeys | breeder | breeders | broiler | broiler breeder | chickens | chicks | chooks | day old chicks | hatchlings | - not applicable (vet)

United Kingdom - English - VMD (Veterinary Medicines Directorate)

eli lilly and company limited - mycoplasma hyopneumoniae - emulsion for injection - inactivated bacterial vaccine - pigs

Australia - English - Department of Health (Therapeutic Goods Administration)

speedx pty ltd - ct792 - mycoplasma ivds - qualitative in vitro diagnostic tests that provide information about infection or exposure to mycoplasma bacteria. these devices are intended for use in hospital, reference or state laboratory settings. these devices are not intended for point of care use.

Australia - English - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct792 - mycoplasma ivds - the aptima mycoplasma genitalium assay is an in vitro nucleic acid amplification test (naat) for the qualitative detection of ribosomal rna (rrna) from m. genitalium on the fully automated panther system. it is intended for use as an aid in the diagnosis of m. genitalium urogenital infections in male and female patients.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva santé animale sa-nv - mycoplasma hyopneumoniae (inactivated) - emulsion for injection - mycoplasma hyopneumoniae, inactivated - mycoplasma - pig